StenoDK_img2_midtjylland

Steno Diabetes Center Aarhus

Strengthening collaboration on diabetes initiatives

In autumn 2017, the Central Denmark Regional Council and the Board of Directors of the Novo Nordisk Foundation approved the project plan for Steno Diabetes Center Aarhus

In autumn 2017, the Central Denmark Regional Council and the Board of Directors of the Novo Nordisk Foundation approved the project plan for Steno Diabetes Center Aarhus, which was established on 1 January 2018.

The vision for Steno Diabetes Center Aarhus is that it will improve the longevity and quality of life of everyone with diabetes in the Central Denmark Region and halt the growth of people developing diabetes in the Region.

The main initiative is establishing an innovative, outpatient diabetes centre at Aarhus University Hospital. The Center intends to become a specialized knowledge and competence centre that puts individuals with diabetes at the centre of its activities.

“The establishment of the Center strengthens the framework for improving patient-centred treatment and preventing late complications. The Center will also strengthen research, education and intersectoral collaboration.” Sten Scheibye, Chairman of the Board, Novo Nordisk Foundation

About Steno Diabetes Center Aarhus

Steno Diabetes Center Aarhus will have four core activities: patient-centred treatment of diabetes and prevention of late complications; patient-related research; developing competencies and education and training; and a special focus on intersectoral collaboration in diabetes initiatives. This means that the Center will focus on developing and improving the coherence of initiatives between hospitals and the municipal and general practice sectors, such as in relation to prevention and early detection of diabetes.

About 8000 people with diabetes are expected to be treated annually at the Center, which will occupy part of the new Forum building being built next to Aarhus University Hospital.

Steno Diabetes Center Aarhus will serve as a driver in developing and disseminating new treatment and prevention methods and ensuring uniform and high-quality treatment in diabetes initiatives across the whole Region. This will be carried out in close collaboration with the other hospitals in the Region and other sectors, including the municipalities and general practitioners.

On 5 September 2017, the Foundation’s Board approved a grant of DKK 1.4 billion to the Central Denmark Region for establishing and operating Steno Diabetes Center Aarhus after the Regional Council approved a detailed plan for the Center on 23 August 2017.

“The Foundation’s ambition is that Denmark can offer the world’s best research-based treatment for diabetes. The establishment of the Center will strengthen the framework for improving patient-centred treatment and preventing late complications. The Center will also strengthen research, education and intersectoral collaboration. The goals are that the people who have diabetes can live longer with a better quality of life and that fewer Danes develop diabetes,” says Sten Scheibye, Chairman of the Board, Novo Nordisk Foundation.

The grant from the Foundation began in 2018 and will last until 2027, with a possible extension thereafter. The Foundation will fund the operating costs of the supplementary treatment of people with diabetes and related prevention initiatives, clinical research, intersectoral collaboration and education and training. In addition, the Foundation will also fund the construction and equipping of a new building in Forum next to Aarhus University Hospital.

Steno Diabetes Center Aarhus is operating from facilities at Aarhus University Hospital until the Center’s new building is ready for use, expected in 2022.

StenoDK_img2_midtjylland